![Syed Rizvi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Syed Rizvi
Chief Tech/Sci/R&D Officer at
POSEIDA THERAPEUTICS, INC.
Net worth: 1 M $ as of 2026-05-30
Profile
Syed Rizvi is currently Chief Medical Officer at Poseida Therapeutics, Inc. starting in 2024 and at Rocket Pharmaceuticals, Inc. starting in 2025.
Memberships include American Society of Clinical Oncology, Inc., American Society of Hematology, and The European Hematology Association.
Former roles include Chief Medical Officer at Caribou Biosciences, Inc. from 2022 to 2023, Chief Medical Officer at Chimeric Therapeutics Ltd. (Australia) from 2020 to 2022, VP-Clinical Development & Medical Affairs at Legend Biotech Corp.
from 2018 to 2020, and Head-Global Medical Affairs at Celgene Corp.
Education includes a doctorate from Dow Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-10 | 407,874 ( 0.37% ) | 1 M $ | 2026-05-30 |
Syed Rizvi active positions
| Companies | Position | Start |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-03-31 |
| ROCKET PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2025-08-31 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
The European Hematology Association
 The European Hematology Association Miscellaneous Commercial ServicesCommercial Services Engages in promoting patient care, research and education in hermatology | Corporate Officer/Principal | - |
Former positions of Syed Rizvi
| Companies | Position | End |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2023-12-30 |
| CHIMERIC THERAPEUTICS LIMITED | Chief Tech/Sci/R&D Officer | - |
| LEGEND BIOTECH CORPORATION | Chief Tech/Sci/R&D Officer | 2020-10-31 |
| CELGENE | Chief Tech/Sci/R&D Officer | - |
Training of Syed Rizvi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
The European Hematology Association
The European Hematology Association Miscellaneous Commercial ServicesCommercial Services Engages in promoting patient care, research and education in hermatology | Commercial Services |
Dow Medical College
 Dow Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Chimeric Therapeutics Ltd. (Australia)
 Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
- Stock Market
- Insiders
- Syed Rizvi
